Paratek Pharmaceuticals, Inc. (PRTK) has 68 open-market insider trades by 10 insiders since 2015. The most active filer is Evan Loh, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Richard J. Lim | Dir | — | 1 | $6.0M | 2016-06-27 |
| Evan Loh | CEO | — | 17 | $2.5M | 2023-09-21 |
| Michael Bigham | Chairman | — | 16 | $2.3M | 2023-09-21 |
| James D. Dondero | 10% Owner | — | 1 | $1.8M | 2023-03-23 |
| Adam Woodrow | Pres | — | 11 | $993K | 2023-09-21 |
| HBM Healthcare Investments (Cayman) Ltd. | 10% | — | 1 | $633K | 2015-05-29 |
| Douglas W. Pagan | CFO | — | 5 | $585K | 2019-04-05 |
| William M. Haskel | CLOSecretary | — | 8 | $426K | 2023-09-21 |
| Randall B. Brenner | — | — | 7 | $355K | 2023-09-21 |
| Thomas John Dietz | Dir | — | 1 | $47K | 2023-09-21 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| William M. Haskel | CLO & Secretary | Sell | $152K | 2023-08-09 |
| Evan Loh | CEO | Sell | $215K | 2023-08-09 |
| Randall B. Brenner | — | Sell | $121K | 2023-08-09 |
| Michael Bigham | Chairman | Sell | $69K | 2023-08-09 |
| James D. Dondero | 10% Owner | Buy | $1.8M | 2023-03-17 |
| Timothy R. Franson | Director | Sell | $13K | 2023-02-21 |
Companies that share insiders with PRTK, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Jeffrey Stein | Director | Sell | $13K | 2023-02-21 |
| Adam Woodrow | President | Sell | $13K | 2022-12-21 |
| William M. Haskel | CLO & General Counsel & Sec. | Sell | $14K | 2022-12-21 |
| Evan Loh | CEO | Sell | $47K | 2022-12-21 |
| Randall B. Brenner | Chief Development & Regulatory | Sell | $9K | 2022-12-21 |
| Michael Bigham | Chairman | Sell | $31K | 2022-12-21 |
| Adam Woodrow | President | Sell | $20K | 2022-12-12 |
| Michael Bigham | Chairman | Sell | $164K | 2022-12-12 |
| Randall B. Brenner | Chief Development & Regulatory | Sell | $58K | 2022-12-12 |